Is Amgen Inc. (AMGN) One of the Best Pharma Stocks to Invest in Now?
Amgen Inc. (NASDAQ:AMGN) is one of the best pharma stocks to invest in now. Amgen Inc.
Amgen Inc (AMGN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 903,557 | $295,743,740 | +16% | 0.1% |
| 2. | 818,000 | $267,739,580 | -38% | 0.04% | |
| 3. | 765,600 | $250,588,536 | -21% | 0.04% | |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 735,880 | $240,860,883 | +1103% | 0.47% |
| 5. | 310,400 | $101,597,024 | +5649% | 0.18% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.50 | 10 | $1,655.00 | 3,582 | 2015-08-19 | Filing | |
| $166.64 | 3,000 | $499,907.10 | 3,572 | 2015-08-19 | Filing | |
| $152.29 | 1,500 | $228,435.00 | 2,000 | 2015-02-05 | Filing | |
| $152.29 | 1,500 | $228,435.00 | 2,000 | 2015-02-05 | Filing | |
| $111.77 | 894 | $99,919.25 | 185,013 | 2014-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $379.12 | 24,291 | $9,209,138.33 | 76,618 | 2026-02-26 | Filing | |
| $379.12 | 30,501 | $11,563,456.77 | 76,618 | 2026-02-26 | Filing | |
| $375.79 | 1,000 | $375,790.00 | 3,423 | 2026-02-19 | Filing | |
| $337.26 | 1,639 | $552,773.24 | 7,225 | 2025-11-20 | Filing | |
| $337.26 | 1,500 | $505,893.75 | 7,225 | 2025-11-20 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 21,108 | $7,426,850 | 2.28% | |
| 2. | 17,209 | $6,054,987 | 0.6% | |
| 3. | 14,746 | $5,188,681 | 1.05% | |
| 4. | 6,853 | $2,411,228 | 0.57% | |
| 5. | 5,481 | $1,928,490 | 0.15% |
News See All
7 Best Pharma Stocks to Invest In Now
On March 24, Scott Chronert, Citi, appeared on CNBC’s 'Closing Bell' to talk about the market and whether it is time to get into equity markets.
Jim Cramer's Hottest GLP-1 and Weight Loss Stock Picks
In an appearance on CNBC's Fast Money in January, Ray Stevens, CEO of Structure Therapeutics, discussed the unmet potential in the obesity market.
10 Most Profitable S&P 500 Stocks to Buy Now
Profitability has moved back to the center of the market conversation.
Amgen Inc. (AMGN): Billionaire Ken Fisher Doubles Bullish Position
Amgen Inc. (NASDAQ:AMGN) is also a staple in the 13F portfolio of Fisher Asset Management. The fund has held a small position in the company since early 2010.
Amgen Inc. (AMGN) Collaborates on Ending Anti-OX40 Clinical Studies
On March 3, TheFly reported that Kyowa Kirin Co., Ltd.
11 Best Kid-Friendly Stocks to Invest In
By late 2025, long-term investing for children has expanded far beyond traditional college savings, evolving into a broader “cradle-to-retirement” financial planning approach.
Amgen Inc. (AMGN) Completes Phase 3 Trial for ABP 206 Opdivo Biosimilar Candidate
On February 27, 2026, Amgen Inc. (NASDAQ:AMGN)’s Phase 3 study (NCT05907122) saw an update.
10 Best Stocks to Invest in During a Recession
Geopolitical tensions are once again having a severe impact on the economic conditions and on investors' decisions in the market as well. CNBC reported on February 28, 2026, that a joint U.S.
Amgen Inc. (AMGN): A Bull Case Theory
We came across a bullish thesis on Amgen Inc. on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on AMGN.
Hedge Fund Resource Center